arrow
C

Caroline J. Springer

University of Manchester
H指数:51
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

打破悖论的panRAF加SRC家族激酶抑制剂CCT3833对突变KRAS驱动的癌症有效

2021-02-0114
OAAI
Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure-Activity Relationships
2019-05-0949
OAAI
Lymph node metastasis evolution drives immune evasion and targeted therapy resistance in gastro-esophageal adenocarcinomas (GEAs)
2017-07-010
PRE
Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
2015-06-15228
OAAI
Novel panRAF inhibitors active in melanomas that are resistant to BRAF-selective, or BRAF-selective/MEK inhibitor combinations
2014-10-010
PRE
BRAF Inhibitors Induce Metastasis in RAS Mutant or Inhibitor-Resistant Melanoma Cells By Reactivating MEK and ERK Signaling

BRAF抑制剂通过重新激活MEK和ERK信号诱导RAS突变或抑制剂抗性黑色素瘤细胞的转移

2014-03-25127
PREAI